Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,238 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Genotyping and phenotyping of beta2-toxigenic Clostridium perfringens fecal isolates associated with gastrointestinal diseases in piglets.
Waters M, Savoie A, Garmory HS, Bueschel D, Popoff MR, Songer JG, Titball RW, McClane BA, Sarker MR. Waters M, et al. J Clin Microbiol. 2003 Aug;41(8):3584-91. doi: 10.1128/JCM.41.8.3584-3591.2003. J Clin Microbiol. 2003. Retraction in: J Clin Microbiol. 2024 May 8;62(5):e0023724. doi: 10.1128/jcm.00237-24 PMID: 12904359 Free PMC article. Retracted.
Disruption of the gene (spo0A) encoding sporulation transcription factor blocks endospore formation and enterotoxin production in enterotoxigenic Clostridium perfringens type A.
Huang IH, Waters M, Grau RR, Sarker MR. Huang IH, et al. Among authors: waters m. FEMS Microbiol Lett. 2004 Apr 15;233(2):233-40. doi: 10.1016/j.femsle.2004.02.014. FEMS Microbiol Lett. 2004. Retraction in: FEMS Microbiol Lett. 2024 Jan 9;371:fnae022. doi: 10.1093/femsle/fnae022 PMID: 15063491 Retracted.
Retraction for Waters et al., "Genotyping and Phenotyping of Beta2-Toxigenic Clostridium perfringens Fecal Isolates Associated with Gastrointestinal Diseases in Piglets.
Waters M, Savoie A, Garmory HS, Bueschel D, Popoff MR, Songer JG, Titball RW, McClane BA, Sarker MR. Waters M, et al. J Clin Microbiol. 2024 May 8;62(5):e0023724. doi: 10.1128/jcm.00237-24. Epub 2024 Apr 12. J Clin Microbiol. 2024. PMID: 38606969 Free PMC article. No abstract available.
Intravenous glibenclamide for cerebral oedema after large hemispheric stroke (CHARM): a phase 3, double-blind, placebo-controlled, randomised trial.
Sheth KN, Albers GW, Saver JL, Campbell BCV, Molyneaux BJ, Hinson HE, Cordonnier C, Steiner T, Toyoda K, Wintermark M, Littauer R, Collins J, Lucas N, Nogueira RG, Simard JM, Wald M, Dawson K, Kimberly WT; CHARM Trial investigators. Sheth KN, et al. Lancet Neurol. 2024 Dec;23(12):1205-1213. doi: 10.1016/S1474-4422(24)00425-3. Lancet Neurol. 2024. PMID: 39577921 Clinical Trial.
1,238 results